title: Molecular approach to the nucleo-melanosomal interaction in human melanoma cells.
abstract: This paper presents evidence that L-tyrosine oxidation products and 5,6-dihydroxyindole, an intermediate of melanin synthesis bind to and modify DNA structure, as tested by extracting cell DNA, using topoisomerase I and denaturation assays. When supercoiled plasmid pCU18 or pBR322 DNAs are treated with 5,6-dihydroxyindole the supercoiled species disappear and are converted to species less mobile in a gel retardation test with respect to relaxed DNA, 5,6-Dihydroxyindole causes an easier acid denaturation of the double helix. The results, that are dose dependent, would point to both intercalation and cross-linking of DNA by 5,6-dihydroxyindole and its oxidation product(s). 3H-L-tyrosine deriving radioactivity, bound to nuclear DNA, is higher at low pH, (5.6) if compared to pH 6.8. The highest radioactivity bound to cell DNA is found during the transition from the amelanotic to the melanotic phenotype in human melanoma cell lines. As a control, the binding of 3H-L-tyrosine radioactivity to human prostate fibroblast DNA was investigated.
authors.affiliation: Department of Basic and Applied Biology, University of L'Aquila, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Miranda
authors.forename: O
authors.initials: O
authors.lastname: Zarivi
authors.forename: F
authors.initials: F
authors.lastname: Amicarelli
authors.forename: A M
authors.initials: AM
authors.lastname: Ragnelli
authors.forename: P
authors.initials: P
authors.lastname: Aimola
authors.forename: R
authors.initials: R
authors.lastname: Porretta
authors.forename: P G
authors.initials: PG
authors.lastname: Natali
authors.forename: A
authors.initials: A
authors.lastname: Arcadi
authors.forename: M
authors.initials: M
authors.lastname: Savino
authors.forename: A
authors.initials: A
authors.lastname: Poma
authors.forename: A
authors.initials: A
authors.lastname: Bonfigli
mesh_terms: D000818:Animals; D002467:Cell Nucleus / Q000201:enzymology*; D004264:DNA Topoisomerases, Type I / Q000378:metabolism / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000378:metabolism; D004278:DNA, Superhelical / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000502:physiology*; D004586:Electrophoresis; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000166:cytology / Q000201:enzymology / Q000502:physiology; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D008081:Liposomes / Q000378:metabolism; D008297:Male; D008545:Melanoma; D014442:Monophenol Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009691:Nucleic Acid Denaturation; D010084:Oxidation-Reduction; D010957:Plasmids / Q000032:analysis; D011471:Prostatic Neoplasms; D011817:Rabbits; D014316:Tritium; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D014443:Tyrosine / Q000378:metabolism
chemical_list: D004273:DNA, Neoplasm; D004278:DNA, Superhelical; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D007211:Indoles; D008081:Liposomes; D014316:Tritium; D014443:Tyrosine; D014442:Monophenol Monooxygenase; D004264:DNA Topoisomerases, Type I; C033871:5,6-dihydroxyindole